126 related articles for article (PubMed ID: 30931855)
1. A Uniquely Modified DKL-based Peptide Probe for Positron Emission Tomography Imaging.
Liu Y; Wang Z; Li X; Kang F; Ma X; Yang W; Ma W; Wang J
Curr Pharm Des; 2019; 25(1):96-103. PubMed ID: 30931855
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of
Yang Y; Zhang J; Zou H; Shen Y; Deng S; Wu Y
J Cancer; 2021; 12(1):244-252. PubMed ID: 33391421
[No Abstract] [Full Text] [Related]
3. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.
Chen K; Ma W; Li G; Wang J; Yang W; Yap LP; Hughes LD; Park R; Conti PS
Mol Pharm; 2013 Jan; 10(1):417-27. PubMed ID: 23190134
[TBL] [Abstract][Full Text] [Related]
5. The uptake exploration of 68Ga-labeled NGR in well-differentiated hepatocellular carcinoma xenografts: Indication for the new clinical translational of a tracer based on NGR.
Gao Y; Wang Z; Ma X; Ma W; Zhao M; Fu T; Li G; Wang S; Wang Z; Yang W; Kang F; Wang J
Oncol Rep; 2017 Nov; 38(5):2859-2866. PubMed ID: 28901442
[TBL] [Abstract][Full Text] [Related]
6. 68Ga-labeled cyclic NGR peptide for microPET imaging of CD13 receptor expression.
Shao Y; Liang W; Kang F; Yang W; Ma X; Li G; Zong S; Chen K; Wang J
Molecules; 2014 Aug; 19(8):11600-12. PubMed ID: 25100253
[TBL] [Abstract][Full Text] [Related]
7. MicroPET imaging of CD13 expression using a (64)Cu-labeled dimeric NGR peptide based on sarcophagine cage.
Li G; Wang X; Zong S; Wang J; Conti PS; Chen K
Mol Pharm; 2014 Nov; 11(11):3938-46. PubMed ID: 25054774
[TBL] [Abstract][Full Text] [Related]
8. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of
Zhao M; Yang W; Zhang M; Li G; Wang S; Wang Z; Ma X; Kang F; Wang J
Tumour Biol; 2016 Sep; 37(9):12123-12131. PubMed ID: 27220318
[TBL] [Abstract][Full Text] [Related]
11. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
12. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the monomeric [
Israel I; Elflein K; Schirbel A; Chen K; Samnick S
Eur J Pharm Sci; 2021 Nov; 166():105964. PubMed ID: 34375678
[TBL] [Abstract][Full Text] [Related]
14. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of 68Ga-DOTA-minigastrin for the detection of cholecystokinin-2/gastrin receptor-positive tumors.
Brom M; Joosten L; Laverman P; Oyen WJ; Béhé M; Gotthardt M; Boerman OC
Mol Imaging; 2011 Apr; 10(2):144-52. PubMed ID: 21439259
[TBL] [Abstract][Full Text] [Related]
16. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
[TBL] [Abstract][Full Text] [Related]
17. In vivo assessment of aminopeptidase N (APN/CD13) specificity of different
Kis A; Dénes N; Szabó JP; Arató V; Jószai I; Enyedi KN; Lakatos S; Garai I; Mező G; Kertész I; Trencsényi G
Int J Pharm; 2020 Nov; 589():119881. PubMed ID: 32946975
[TBL] [Abstract][Full Text] [Related]
18. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.
Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M
J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127
[TBL] [Abstract][Full Text] [Related]
20. In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR).
Máté G; Kertész I; Enyedi KN; Mező G; Angyal J; Vasas N; Kis A; Szabó É; Emri M; Bíró T; Galuska L; Trencsényi G
Eur J Pharm Sci; 2015 Mar; 69():61-71. PubMed ID: 25592229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
